Max Healthcare Institute Limited announces Q2 2026 results and expansion plans
Max Healthcare Institute Ltd · Healthcare Services
What the filing says
- Approved unaudited standalone and consolidated financial results for quarter and half-year ended September 30, 2026.
- Approved ₹93 crore capital expenditure for expansion of Max Super Speciality Hospital, Sector-128, Noida operated by subsidiary Crosslay Remedies Limited.
- Approved ₹97 crore capital expenditure for construction of additional floors at Max Super Speciality Hospital, Vaishali, also run by Crosslay; appointed Dr. Dharmender Kumar as Director & Chief - Public Affairs effective November 1, 2026.
Why it's rated notable: the year-on-year change is 16% (10% to 20% for adverse news)
Original filing
Announcement under Regulation 30 (LODR)-Change in Management
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Max Healthcare Institute Ltd
- Financial resultsNotable· Adverse for the businessMax Healthcare Institute Limited announces Q2 2026 financials and key approvals
Other capex / expansion filings this fortnight
- Studds Accessories Ltd starts commercial production at new Manufacturing Facility-V
- Sagar Cements Q2 FY27 un-audited results: consolidated loss after tax ₹5,154 lakhs
- Elevate Campuses Limited expands hostel services at O.P. Jindal Global University
- Vinati Organics announces ₹500 crore capex plan for specialty chemical projects
- Waaree Energies Ltd subsidiary starts commercial production of 1.6 GW solar lines in USA
- Monolithisch India Limited Q2 H1 FY27 earnings call transcript and operational update
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.